Cargando…
AZD9773, a novel anti-TNFα immune Fab in development for severe sepsis and septic shock: demonstration of safety and efficacy in a murine CLP sepsis model
Autores principales: | Newham, P, Ceuppens, P, Das, S, Yates, JWT, Knight, R, McKay, JS |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3239284/ http://dx.doi.org/10.1186/cc10410 |
Ejemplares similares
-
AZD9773 is a novel and potent anti-TNFα polyclonal ovine immune Fab
por: Newham, P, et al.
Publicado: (2011) -
Preclinical pharmacodynamics and safety profiling of AZD9773: a novel anti-TNFα polyclonal immune ovine Fab similar to D-CytoFab
por: Newham, P, et al.
Publicado: (2011) -
Safety and tolerability of an ovine-derived polyclonal anti-TNFα Fab fragment (AZD9773) in patients with severe sepsis
por: Morris, P, et al.
Publicado: (2011) -
A placebo-controlled, double-blind, dose-escalation study to assess the safety, tolerability and pharmacokinetics/pharmacodynamics of single and multiple intravenous infusions of AZD9773 in patients with severe sepsis and septic shock
por: Morris, Peter E, et al.
Publicado: (2012) -
Characterization of the complex formed between a potent neutralizing ovine-derived polyclonal anti-TNFα Fab fragment and human TNFα
por: Abbott, W. Mark, et al.
Publicado: (2013)